Analystreport

Arcus Biosciences, Inc. (NYSE: RCUS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.

Arcus Biosciences, Inc.  (RCUS) 
Last arcus biosciences, inc. earnings: 3/5 04:10 pm Check Earnings Report